Cuorips (TSE:4894) Debt-to-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cuorips Debt-to-Asset?

Cuorips's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0.00 Mil. Cuorips's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0.00 Mil. Cuorips's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was 円5,760.57 Mil. Cuorips's debt to asset for the quarter that ended in Sep. 2024 was 0.00.

Cuorips Debt-to-Asset Historical Data

The historical data trend for Cuorips's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cuorips Debt-to-Asset Chart

Cuorips Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Cuorips Quarterly Data
	Mar21	Mar22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Cuorips's Debt-to-Asset

For the Biotechnology subindustry, Cuorips's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cuorips's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cuorips's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Cuorips's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Cuorips Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Cuorips's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	6184.738
	=	0.00

Cuorips's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	5760.567
	=	0.00

Cuorips (TSE:4894) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Cuorips Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Cuorips's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cuorips Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cuorips Inc (TSE:4894) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023

Website

https://www.cuorips.co.jp

Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.

Cuorips Headlines

No Headlines